Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment.

Autor: Njenga SM; Eastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research Institute, Nairobi, Kenya., Kanyi H; Eastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research Institute, Nairobi, Kenya., Okoyo C; Eastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research Institute, Nairobi, Kenya.; Department of Epidemiology, Statistics and Informatics, Kenya Medical Research Institute, Nairobi, Kenya., Githinji E; Eastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research Institute, Nairobi, Kenya., Mwatele C; Eastern and Southern Africa Centre of International Parasite Control, Kenya Medical Research Institute, Nairobi, Kenya., Matendechero SH; Vector-Borne and Neglected Tropical Diseases Unit, Ministry of Health, Nairobi, Kenya., Omondi WP; Vector-Borne and Neglected Tropical Diseases Unit, Ministry of Health, Nairobi, Kenya., Gitahi PN; Vector-Borne and Neglected Tropical Diseases Unit, Ministry of Health, Nairobi, Kenya., Owaga C; Evidence Action, Nairobi, Kenya., Onsongo JK; WHO Country Office, World Health Organization, Nairobi, Kenya., Gass K; NTD Support Center, Task Force for Global Health, Atlanta, Georgia, United States of America.

Publikováno v: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Jul 08; Vol. 18 (7), pp. e0011942. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).